Diseases Related News
A new generation of targeted therapies for advanced diseases
HEQ discusses the importance of targeted therapies for advanced diseases with CEO of Diaccurate, Dominique Bridon.
Adopting a personalised approach to medicine and developing novel...
Sleep apnoea severity can be reduced by repurposed drugs
Existing medications could be repurposed to successfully reduce the severity of sleep apnoea by at least 30%, new research has revealed.
Professor Danny Eckert, Principal...
